Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

HCW Biologics (HCWB) Operating Margin (2022 - 2025)

HCW Biologics (HCWB) has disclosed Operating Margin for 4 consecutive years, with 21093.91% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Operating Margin fell 2022985.0% year-over-year to 21093.91%, compared with a TTM value of 2811.71% through Sep 2025, down 175100.0%, and an annual FY2024 reading of 1148.5%, down 24354.0% over the prior year.
  • Operating Margin was 21093.91% for Q3 2025 at HCW Biologics, up from 52561.24% in the prior quarter.
  • Across five years, Operating Margin topped out at 60.33% in Q1 2022 and bottomed at 52561.24% in Q2 2025.
  • Average Operating Margin over 4 years is 8910.23%, with a median of 801.78% recorded in 2024.
  • The sharpest move saw Operating Margin soared 1213382bps in 2024, then tumbled -5011542bps in 2025.
  • Year by year, Operating Margin stood at 422.45% in 2022, then plummeted by -93bps to 813.31% in 2023, then grew by 1bps to 801.78% in 2024, then tumbled by -2531bps to 21093.91% in 2025.
  • Business Quant data shows Operating Margin for HCWB at 21093.91% in Q3 2025, 52561.24% in Q2 2025, and 38811.49% in Q1 2025.